ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB042

Prevalence of Cognitive Impairment in Patients with Iron Deficiency Anemia and CKD Introduction

Session Information

Category: Anemia and Iron Metabolism

  • 200 Anemia and Iron Metabolism

Authors

  • Ruiz Saucedo, Gonzalo, Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico
  • Lopezlievanos, Miguel Angel, Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico
  • Perez-Navarro, L. Monserrat, Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico
Background

Cognitive impairment is highly prevalent among the population with chronic kidney disease. Even in early stages, it has been described as occurring in 10% of cases, and in more advanced stages, it can reach up to 50%.. Understanding the prevalence of cognitive impairment and the most affected domains on the MoCA Test in the population with chronic kidney disease could help better characterize this comorbidity and identify areas of opportunity to prevent further cognitive decline and its progression to dementia.

Methods

Cross-sectional study of adult patients with anemia asocida a deficit de hierrro and CKD. Variables clinical, biochemical, and MoCA Test were analyzed and Pearson correlation was realized. A p-value<0.05 was considered statistically significant.

Results

A total of 47 adult patients were analyzed (68% females). The average age was 56.1 ± 14.5, 55% of patients with CKD 4 and 45% CKD, mean Hb 11.12 ± 1.1, TSI 18.8 ± 6.8, MCV 87.6 ± 6.41, MCH 29.7 ± 2.6 and median Ferritin 95.65 (3.9 – 789). 36% of patients had Hb <11 mg/dL. The distribution by educational level was 45% had ≤6 years of schooling, 21% between 79 years of schooling and 34% of patients had ≥10 years of schooling. 23% had a MoCA score >26 (normal), 49% with mild impairment, 25% with moderate impairment, and only 2% with severe impairment.

Conclusion

In our study, which included a Mexican population with chronic kidney disease in stages 3b and 4 and anemia associated with absolute iron deficiency, cognitive impairment was present in 77%. According to the MoCA test, patients with chronic kidney disease in stages 3b and 4 had greater impairment in the visual-executive domains. In turn, the domain with the greatest preservation was orientation

Digital Object Identifier (DOI)